Colon Cancer Test

A new gene test is said to predict whether certain forms of colon cancer are likely to return in former patients. A large number of colon cancer patients have the cancer removed via chemotherapy, but often times there may a chance of round two in the future. This would shed great light onto the prevention and early detection of cancer coupled with virtual colonoscopy scans. According to Reuters, "Molecular diagnostics company Genomic Health Inc said last month that a pivotal trial of its OncoType DX colon cancer assay showed that it could predict cancer recurrence risk but did not meet a secondary goal of predicting a patient's response to standard chemotherapy after surgery." The test may be available and FDA approved by 2010 researchers say, and the findings will be made available at a conference soon.